Finance

Lists
Why is IMRX down 6.81%?
Dive Deeper
IMRX:NASDAQ
Immuneering Corp
$3.49
-6.81%
(-0.25) 1D
$3.50
+0.29% (+0.0100)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
$3.76
High
$3.94
Low
$3.44
Mkt. cap
225.72M
Avg. vol.
730.86K
Volume
0.00
52-wk high
$8.48
52-wk low
$3.38
EPS
-$1.03
Beta
0.46
Shares outstanding
64.76M
No. of employees
65
Open
$3.76
High
$3.94
Low
$3.44
Mkt. cap
225.72M
Avg. vol.
730.86K
Volume
0.00
52-wk high
$8.48
52-wk low
$3.38
EPS
-$1.03
Beta
0.46
Shares outstanding
64.76M
No. of employees
65
News stories
From web sources and news partners
About Immuneering Corp
CEO-
Employees65
Founded2008
Headquarters-
SectorBiotechnology
Websiteimmuneering.com
Analyst ratings
Based on 4 analysts giving stock ratings to IMRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current $3.49
$18.00 (+415.76%)
Average
$13.75 (+293.98%)
Lowest
$11.00 (+215.19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$14.00
+301.1%
10/30/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$11.00
+215.2%
10/29/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$12.00
+243.8%
08/17/2026
Ami Fadia
Needham
Buy
Reiterated
$18.00
+415.8%
08/05/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
$17.00
+387.1%
07/08/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$20.00
+473.1%
05/19/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$30.00
+759.6%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.25M
10.65M
14.00M
20.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.49M
4.68M
5.00M
5.06M
Operating expense
13.75M
15.34M
19.00M
25.79M
Total operating expenses
13.75M
15.34M
19.00M
25.79M
Operating income
-13.75M
-15.34M
-19.00M
-25.79M
Other non operating income
155.92K
109.01K
647.20K
390.84K
EBT including unusual items
-11.58M
-13.46M
-17.27M
-24.19M
EBT excluding unusual items
-11.74M
-13.87M
-17.27M
-24.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.58M
-13.46M
-17.27M
-24.19M
Net profit margin
-
-
-
-
Earnings per share
-0.18
-0.21
-0.27
-0.37
Interest and investment income
1.86M
1.36M
1.08M
1.20M
Interest expense
-
-
-
-
Net interest expenses
1.86M
1.36M
1.08M
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.67M
-15.25M
-18.91M
-25.69M
Gain or loss from assets sale
2.09K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps